36 patents
Page 2 of 2
Utility
Methods of treating cancer patients with farnesyltransferase inhibitors
28 Dec 21
The present invention relates to the field of molecular biology and cancer biology.
Antonio Gualberto, Catherine Rose Scholz
Filed: 13 Jun 18
Utility
Methods of Treating Cancer Patients with Farnesyltransferase Inhibitors
9 Dec 21
The present invention relates to the field of molecular biology and cancer biology.
Antonio Gualberto, Catherine Rose Scholz
Filed: 17 Aug 21
Utility
Methods of treating cancer patients with farnesyltransferase inhibitors
21 Sep 21
The present invention relates to the field of molecular biology and cancer biology.
Antonio Gualberto, Catherine Rose Scholz
Filed: 2 Nov 17
Utility
Synthesis of Tipifarnib
12 Aug 21
Provided herein are methods of preparing a desired enantiomer 6-[amino(4-chlorophenyl) (1-methyl-1H-imidazol-5-yl) methyl]-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone, otherwise known as tipifarnib.
Pingda REN, Xiaohu DENG, Wanping MAI
Filed: 17 May 19
Utility
Substituted Inhibitors of Menin-mll and Methods of Use
8 Apr 21
The present disclosure provides methods of inhibiting the interaction of menin with MLL1, MLL2 and MLL-fusion oncoproteins.
Tao WU, Liansheng LI, Yi WANG, Pingda REN, Jolanta GREMBECKA, Tomasz CIERPICKI, Szymon KLOSSOWSKI, Jonathan POLLOCK, Dmitry BORKIN
Filed: 30 Jul 20
Utility
Methods of treating cancer with farnesyltransferase inhibitors
19 Oct 20
The present invention relates to the field of cancer therapy.
Antonio Gualberto
Filed: 20 Nov 17
Utility
Substituted inhibitors of menin-MLL and methods of use
21 Sep 20
Tao Wu, Liansheng Li, Yi Wang, Pingda Ren, Jolanta Grembecka, Tomasz Cierpicki, Szymon Klossowski, Jonathan Pollock, Dmitry Borkin
Filed: 14 Mar 17
Utility
Bridged bicyclic inhibitors of menin-MLL and methods of use
24 Aug 20
Tao Wu, Liansheng Li, Yi Wang, Pingda Ren, Jolanta Grembecka, Tomasz Cierpicki, Szymon Klossowski, Jonathan Pollock, Dmitry Borkin
Filed: 14 Mar 17
Utility
Methods of Treating Cancer with Farnesyltransferase Inhibitors
5 Aug 20
The present invention relates to the field of cancer therapy.
Antonio Gualberto
Filed: 6 Aug 18
Utility
Substituted Inhibitors of Menin-mll and Methods of Use
8 Jul 20
The present disclosure provides methods of inhibiting the interaction of menin with MLL1, MLL2 and MLL-fusion oncoproteins.
Tao WU, Liansheng LI, Pingda REN
Filed: 18 Sep 18
Utility
Methods and Compositions for Inhibiting the Interaction of Menin with MLL Proteins
27 May 20
The present disclosure provides compositions and methods of use to inhibit the interaction of menin with MLL1, MLL2 and MLL-fusion oncoproteins.
Liansheng LI, Tao WU, Jun FENG, Pingda REN, Yi LIU, Jolanta GREMBECKA, Tomasz CIERPICKI, Dmitry BORKIN, Jonathan POLLOCK
Filed: 6 Jun 18
Utility
Methods and compositions for inhibiting the interaction of menin with MLL proteins
16 Mar 20
The present disclosure provides compositions and methods of use to inhibit the interaction of menin with MLL1, MLL2 and MLL-fusion oncoproteins.
Jolanta Grembecka, Tomasz Cierpicki, Dmitry Borkin, Jonathan Pollock, Liansheng Li, Tao Wu, Jun Feng, Pingda Ren, Yi Liu
Filed: 2 Jun 16
Utility
Methods of Treating Cancer with Farnesyltransferase Inhibitors
1 Jan 20
The present invention relates to the field of cancer therapy.
Antonio Gualberto, Catherine Rose Scholz
Filed: 13 Aug 19
Utility
Methods of Treating Cancer with Farnesyltransferase Inhibitors
1 Jan 20
The present invention relates to the field of cancer therapy.
Antonio Gualberto, Catherine Rose Scholz
Filed: 20 Feb 18
Utility
Methods of treating cancer patients with farnesyltransferase inhibitors
11 Nov 19
The present invention relates to the field of molecular biology and cancer biology.
Antonio Gualberto, Catherine Rose Scholz
Filed: 15 Aug 16
Utility
Methods of treating cancer with farnesyltransferase inhibitors
30 Sep 19
The present invention relates to the field of cancer therapy.
Antonio Gualberto, Catherine Rose Scholz
Filed: 4 Apr 18